Advanced Search

 

Study ID Status Title Patient Level Data
203093 Completed Efficacy of a carbohydrate drink on speed, agility and power in school going children
203120 Completed Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
203121 Completed Study 203121: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Atopic Dermatitis
203127 Active, not recruiting Impact of vaccination against pneumococcal disease on the morbidity of Acute Otitis Media in Colombian children < 5 years of age
203129 Completed Impact of Pneumococcal Conjugate Vaccines on Otitis Media and Acute Otitis Media in Swedish Children
203153 Completed A post-marketing, observational, retrospective, cohort study to assess the safety of RefortrixTM (Tdap) when administered during pregnancy in a maternal immunization program in Brazil.
203158 Recruiting Exploration of the peripheral immune system in subjects with New Onset T1 Diabetes (NOT1D)
203160 Completed Clinical Evaluation of Oral Hygiene Products in an In Situ Caries Model
203161 Withdrawn Clinical Efficacy of Fluoride Toothpastes Using an In Situ Caries Model
203162 Recruiting An escalating dose, randomized, placebo-controlled, incomplete-block, 2-period cross-over study to assess the dose response for topical efficacy via airway responsiveness to adenosine-5'-monophosphate (AMP) challenge and the dose response for systemic activity via 24 hour (h) plasma cortisol suppression and thereby the relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjects
203167 Recruiting A multicentre, randomised, double-blind (sponsor-unblinded), placebo-controlled, repeat dose study to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and efficacy of GSK2982772 in subjects with active plaque-type psoriasis
203168 Recruiting A multicenter, randomized, double-blind (sponsor-unblinded), placebo-controlled study to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and efficacy of GSK2982772 in subjects with moderate to severe rheumatoid arthritis
203818 Recruiting A Pilot Study to Evaluate Molecular Imaging Methods in Primary Sjögren’s Syndrome
203820 Completed A two-part trial to evaluate the safety, tolerability, clinical effect and systemic exposure potential of topically applied GSK2981278 ointment in subjects with plaque psoriasis
203821 Completed Summary Document Analysis Plan for the Meta-Analysis and Assessment of Serious Event Outcomes in Patients with Persistent Asthma Receiving Salmeterol in Combination with Fluticasone as ADVAIR
204471 Completed A multi-centre, open label, single arm, 32-week treatment study in subjects with severe eosinophilic asthma not optimally controlled with current omalizumab treatment who are switched from omalizumab to mepolizumab 100mg subcutaneous (study number 204471- the OSMO study)
204476 Not yet recruiting Impact of a multiple micronutrient (MMN) beverage powder on vaccine response in school children (7-10yrs; inclusive) in Bangladesh: a randomised, double blind controlled trial
204477 Recruiting Clinical study to measure the impact of fortified malt based food on immunity outcomes in school children
204485 Active, Not Recruiting Epidemiological study Assessing the Burden of Illness Related to Severe Asthma in Quebec
204486 Recruiting Cross-vaccination study of GSK Biologicals’ Lyophilized formulation of the Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A) in subjects who previously received placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) studies
204499 Not yet recruiting A Multicentre Observational Study with 90-days Follow-up Period to Evaluate Clinical Practice Variability as well as Clinical and Organisational Factors Related to Outcomes for COPD Hospital Admissions in Portugal
204500 Completed Salford Lung Studies: Follow-up Interviews on Patient-Centred Outcomes
204503 Terminated Assessment of cognitive function and mobility in individuals with pain
204509 Completed A single-centre, follow-up study to investigate the effect of GSK2245035 on nasal allergic reactivity in subjects who completed treatment in study TL7116958 in 2014 Study Listed on ClinicalStudyDataRequest.com
204511 Recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of ANORO administered in Korean subjects with chronic obstructive pulmonary disease (COPD) in usual practice

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.